Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

PFAS exposure increases gestational diabetes risk

A review of 130 studies links PFAS exposure to gestational diabetes, highlighting the need for further research on diabetes outcomes and environmental factors.

19 Jan 2026

Blood metabolites reveal who will develop type 2 diabetes years before diagnosis

This large prospective study integrated blood metabolomics, genetics, and lifestyle data to identify hundreds of metabolites associated with long-term risk of type 2 diabetes in initially healthy adults. A validated 44-metabolite signature improved risk prediction beyond conventional factors, offering insights into biological pathways and opportunities for earlier, more precise prevention.

18 Jan 2026

Incretin-based diabetes drugs show potential protective effects against dementia

A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both incretin-based, are associated with a reduced risk of dementia.

15 Jan 2026

Screen time may increase body fat in children

A study links excessive screen time in children to higher body fat and poor metabolic health, highlighting cardiorespiratory fitness as a protective factor.

15 Jan 2026

Post-meal blood sugar spikes linked to increased Alzheimer's risk

A new study led by researchers from the University of Liverpool has found that spikes in blood sugar after meals may increase the risk of Alzheimer's disease.

14 Jan 2026

PFAS exposure linked to gestational diabetes and insulin problems

Exposure to per- and polyfluoroalkyl substances (PFAS), a class of highly persistent environmental chemicals commonly referred to as "forever chemicals," is associated with a higher risk of gestational diabetes mellitus and altered markers of insulin resistance and insulin secretion, according to a new systematic review and meta-analysis led by researchers at the Icahn School of Medicine at Mount Sinai.

14 Jan 2026

New metabolomic signature predicts type 2 diabetes risk beyond traditional factors

Diabetes, a metabolic disease, is on the rise worldwide, and over 90 percent of cases are type 2 diabetes, where the body does not effectively respond to insulin.

14 Jan 2026

Light daily movement linked to longer life in cardiometabolic disease

Researchers determine the impact of light physical activity on mortality in people with cardiovascular-kidney-metabolic syndrome.

14 Jan 2026

Preclinical study reveals potential new treatment for severe liver fibrosis

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis - a dangerous, disease-induced build-up of scar tissue in the liver that often leads to cancer.

13 Jan 2026

Vegetarian women show subtle changes in cellular health markers

Slovak university women on vegetarian diets exhibit small bioelectrical impedance variations, suggesting potential insights into body composition and health.

13 Jan 2026

Weight loss normalizes fat tissue at cellular level

It is well known that obesity typically leads to inflammation and dysfunction of fat tissue that increases the risk of developing metabolic diseases such as diabetes and cardiovascular diseases.

12 Jan 2026

Research shows benefits of lifestyle interventions in reducing the risk of gestational diabetes

New research co-authored by Professor Fionnuala McAuliffe, UCD School of Medicine, and led by the University of Liverpool, has demonstrated the significant benefits of lifestyle interventions in reducing the risk of gestational diabetes.

9 Jan 2026

Long-term diabetes changes red blood cells, increasing cardiovascular disease risk

The longer a person has type 2 diabetes, the greater the risk of cardiovascular disease. A new study from Karolinska Institutet, published in the journal Diabetes, shows that changes in red blood cells may be an important explanation, and identifies a specific molecule as a possible biomarker.

9 Jan 2026

California ends Medicaid coverage of weight loss drugs despite TrumpRx plan

Many low-income Californians prescribed wildly popular weight loss drugs lost their coverage for the medications at the start of the new year.

9 Jan 2026

Global analysis shows widespread eligibility for GLP-1 weight management drugs

The worldwide prevalence of obesity has more than doubled in the last three decades, bringing with it an increase in weight-related diseases like diabetes, cardiovascular disease, and cancers.

8 Jan 2026

Natural daylight during office hours improves glucose stability in type 2 diabetes

Natural daylight exposure during office hours improves glucose control and boosts fat oxidation in individuals with type 2 diabetes, enhancing metabolic health.

8 Jan 2026

Weight loss drugs may cause nutritional deficiencies without proper guidance

People prescribed the new generation of weight loss drugs may not receive sufficient nutritional guidance to support safe and sustainable weight loss, leaving them vulnerable to nutritional deficiencies and muscle loss, say experts at UCL and the University of Cambridge.

7 Jan 2026

Reprogramming immunity to protect beta cells in type 1 diabetes

In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a bold new front. With $1 million in funding from Breakthrough T1D, the leading global T1D research and advocacy organization, Leonardo Ferreira, Ph.D., assistant professor of Pharmacology and Immunology, and his collaborators at partnering institutions will explore a new approach to treating – and potentially curing – the disease.

7 Jan 2026

Millions in Great Britain using or seeking weight loss drugs

An estimated 1.6 million adults in England, Wales and Scotland used drugs such as Wegovy and Mounjaro to help lose weight between early 2024 and early 2025, according to a new study by UCL (University College London) researchers.

7 Jan 2026

Gut-microbe-derived molecules may play a key role in shaping the developing immune system

An international research team has uncovered compelling evidence that gut-microbe-derived molecules may play an important role in shaping the developing immune system during early childhood.

7 Jan 2026

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

PFAS exposure increases gestational diabetes risk

Blood metabolites reveal who will develop type 2 diabetes years before diagnosis

Incretin-based diabetes drugs show potential protective effects against dementia

Screen time may increase body fat in children

Post-meal blood sugar spikes linked to increased Alzheimer's risk

PFAS exposure linked to gestational diabetes and insulin problems

New metabolomic signature predicts type 2 diabetes risk beyond traditional factors

Light daily movement linked to longer life in cardiometabolic disease

Preclinical study reveals potential new treatment for severe liver fibrosis

Vegetarian women show subtle changes in cellular health markers

Weight loss normalizes fat tissue at cellular level

Research shows benefits of lifestyle interventions in reducing the risk of gestational diabetes

Long-term diabetes changes red blood cells, increasing cardiovascular disease risk

California ends Medicaid coverage of weight loss drugs despite TrumpRx plan

Global analysis shows widespread eligibility for GLP-1 weight management drugs

Natural daylight during office hours improves glucose stability in type 2 diabetes

Weight loss drugs may cause nutritional deficiencies without proper guidance

Reprogramming immunity to protect beta cells in type 1 diabetes

Millions in Great Britain using or seeking weight loss drugs

Gut-microbe-derived molecules may play a key role in shaping the developing immune system

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in